Table 2 Specifications of CIKs infusions in COVID-19 infected cancer patients with ACT
Advanced Cancer types | Case | Number of ACT cycles | Total number of ACT infused | Number of severe cases |
|---|---|---|---|---|
lung | 5 | 14 | 39.13 × 109 | 0 |
ovarian | 5 | 13 | 39.02 × 109 | 1 |
colon -rectal | 4 | 11 | 31.46 × 109 | 1 |
breast | 3 | 7 | 20.65 × 109 | 0 |
gastric | 3 | 7 | 21.98 × 109 | 0 |
pancreatic | 2 | 4 | 12.8 × 109 | 0 |
kidney | 2 | 7 | 20.76 × 109 | 0 |
laryngocarcinoma | 2 | 4 | 11.98 × 109 | 1 |
hepatobiliary | 2 | 6 | 17.88 × 109 | 0 |
liver | 2 | 5 | 15.25 × 109 | 0 |
bladder | 1 | 1 | 3.02 × 109 | 0 |
cervical | 1 | 2 | 6.01 × 109 | 0 |
nasopharynx | 1 | 3 | 8.91 × 109 | 0 |
esophagus | 1 | 3 | 8.89 × 109 | 1 |
sarcoma | 1 | 2 | 6.22 × 109 | 0 |